In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
about
Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2Controversial data on simvastatin in asthma: What about the rat model?Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsToll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethalOxidized phospholipids protect against lung injury and endothelial barrier dysfunction caused by heat-inactivated Staphylococcus aureus.Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse modelHeat shock factor 1 protects against lung mycoplasma pneumoniae infection in mice.Inhaled therapeutics for prevention and treatment of pneumoniaCellular Microbiology of Mycoplasma canis.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.MALP-2 pre-treatment modulates systemic inflammation in hemorrhagic shock.Intratracheal macrophage-activating lipopeptide-2 reduces metastasis in the rat lung.Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.Modulation of asthma and allergy by addressing toll-like receptor 2.Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model.TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.Efficacy of macrophage-activating lipopeptide-2 combined with interferon-gamma in a murine asthma model.Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia.
P2860
Q28384039-88C8F6F7-38EB-4007-AAF4-942210142E24Q33855464-1BC8EBB5-23C8-44CB-9CBA-E8DF9B1A8037Q34023899-43264480-2969-47B7-BB2B-3073450EB00DQ35164987-7340E51C-44BC-4825-A0F4-F980A7F8E27FQ35178692-781CC2A8-6535-4688-B7C3-6128857420F6Q35596295-362FC61C-5448-41AD-AE9B-7209D3EFFCF1Q35649459-71AD4341-939F-4C99-84B9-AB770EF4D43BQ35925366-2907A830-2270-4910-B43C-F40AB7DD4860Q37002275-D6123316-2EF0-4B9A-888E-DC75850A1B66Q38195597-C46954F4-EEBB-4E13-ADD8-35958C2BEBF2Q40275846-B5AFA661-454E-4EFB-B937-893AA0597016Q40669705-0EB96D9D-6E34-441F-9044-187C2CB20565Q42210341-25749498-90B4-4492-8B90-87D8E8F3BF14Q43065052-995A14FF-CAFC-47A4-9ECD-23D05437556AQ43141763-A6FACF2A-0DB3-4E76-8F22-D0B21A823007Q45706268-06680725-E8E2-4227-9A8B-2C7E560D3D88Q46496990-032F5108-1B90-4C6E-A3B0-FCF49F0F4AA1Q48756180-340548E5-B063-49BE-8135-E24EAE5C95CAQ52915313-7AC1DF4B-7854-4D6A-BC5F-E19B4610CDED
P2860
In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
In vivo effects of a synthetic ...... s after pulmonary application.
@en
In vivo effects of a synthetic ...... s after pulmonary application.
@nl
type
label
In vivo effects of a synthetic ...... s after pulmonary application.
@en
In vivo effects of a synthetic ...... s after pulmonary application.
@nl
prefLabel
In vivo effects of a synthetic ...... s after pulmonary application.
@en
In vivo effects of a synthetic ...... s after pulmonary application.
@nl
P2093
P2860
P1476
In vivo effects of a synthetic ...... s after pulmonary application.
@en
P2093
Anke Lührmann
Johannes E Gessner
Julia Skokowa
Michaela Hanke
Peter F Mühlradt
Reinhard Pabst
Thomas Tschernig
Ursula Deiters
P2860
P304
P356
10.1128/IAI.70.7.3785-3792.2002
P407
P577
2002-07-01T00:00:00Z